For the Inventor, By the Inventor

Enter assignee name

San Carlos, CA, United States of America

Iovance Biotherapeutics, Inc.

USPTO Granted Patents = 110

EPO Patents = 13

Trademarks = 11

Forward Citations = 805

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Michael T Lotze (74 out of 81 patents)

Seth Wardell (57 out of 61 patents)

James Bender (53 out of 71 patents)

4. Ian Frank (21 out of 21 patents)

5. Cecile Chartier-Courtaud (10 out of 14 patents)

6. Krit Ritthipichai (9 out of 10 patents)

7. Michelle R Simpson-Abelson (6 out of 6 patents)

8. Anne Brooks (5 out of 5 patents)

9. Steve Macrides (5 out of 5 patents)

10. Kristin Lanzi (5 out of 5 patents)

11. Christopher Mosychuk (4 out of 4 patents)

12. Brian Rabinovich (4 out of 4 patents)

13. Maria Fardis (4 out of 28 patents)

14. Anand Veerapathran (3 out of 3 patents)

15. Aishwarya Gokuldass (3 out of 3 patents)

Core Competencies:

Tumor Infiltrating Lymphocytes

Immunotherapy

T-Cell Co-Culture

Neoantigens

Gene Editing

Cytokine Combinations

PD-L1 Binding Proteins

Cell Therapy Products

Patient-Specific Immunotherapy

Expansion Processes

Restimulation

AKT Pathways

110 patents: Sort by Forward Citations

1. 12678499 - TREATMENT WITH TUMOR INFILTRATING LYMPHOCYTE THERAPIES IN COMBINATION WITH CTLA-4 AND PD-1 INHIBITORS (2026-07-14),

2. 12673982 - Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion (2026-07-07),

3. 12655389 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-06-16),

4. 12648962 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-06-09),

5. 12642816 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-06-02),

6. 12642268 - CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-06-02),

7. 12636318 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-05-26),

8. 12622927 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-05-12),

9. 12612598 - Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy (2026-04-28),

10. 12570961 - METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS (2026-03-10),

11. 12570959 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-03-10),

12. 12558375 - PROCESSES FOR PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY (2026-02-24),

13. 12553031 - METHODS AND COMPOSITIONS FOR T-CELL COCULTURE POTENCY ASSAYS AND USE WITH CELL THERAPY PRODUCTS (2026-02-17),

14. 12548651 - Identification of clonal neoantigens and uses thereof (2026-02-10),

15. 12516291 - PROCESSES FOR THE PRODUCTION OF TUMOR INFILTRATING LYMPHOCYTES (TILS) AND METHODS OF USING THE SAME (2026-01-06),

Company Overview

Iovance Biotherapeutics, Inc., based in San Carlos, CA, specializes in innovative cell therapy solutions, particularly focusing on tumor infiltrating lymphocytes (TILs) for cancer treatment. The company is at the forefront of immunotherapy, leveraging advanced techniques such as T-cell co-culture and gene editing to enhance therapeutic efficacy. Iovance's research encompasses neoantigens and cytokine combinations, aiming to develop effective cell therapy products that target various malignancies, thereby contributing to the evolving landscape of cancer treatment.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

110 Patents

#2 in San Carlos, CA

#789 in California

#3,477 in US

#7,159 in the World

San Carlos, CA, United States of America

Iovance Biotherapeutics, Inc.

Forward Citations = 805

36 inventors:

Michael T Lotze (74 out of 81 patents)

Seth Wardell (57 out of 61 patents)

James Bender (53 out of 71 patents)

4. Ian Frank (21 out of 21 patents)

5. Cecile Chartier-Courtaud (10 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iovance Biotherapeutics, Inc.. Retrieved from https://idiyas.com/company/iovance-biotherapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…